436 related articles for article (PubMed ID: 29774024)
1. Quantification of HLA-DM-Dependent Major Histocompatibility Complex of Class II Immunopeptidomes by the Peptide Landscape Antigenic Epitope Alignment Utility.
Álvaro-Benito M; Morrison E; Abualrous ET; Kuropka B; Freund C
Front Immunol; 2018; 9():872. PubMed ID: 29774024
[TBL] [Abstract][Full Text] [Related]
2. Distinct editing functions of natural HLA-DM allotypes impact antigen presentation and CD4
Álvaro-Benito M; Morrison E; Ebner F; Abualrous ET; Urbicht M; Wieczorek M; Freund C
Cell Mol Immunol; 2020 Feb; 17(2):133-142. PubMed ID: 30467419
[TBL] [Abstract][Full Text] [Related]
3. Predicting CD4 T-cell epitopes based on antigen cleavage, MHCII presentation, and TCR recognition.
Schneidman-Duhovny D; Khuri N; Dong GQ; Winter MB; Shifrut E; Friedman N; Craik CS; Pratt KP; Paz P; Aswad F; Sali A
PLoS One; 2018; 13(11):e0206654. PubMed ID: 30399156
[TBL] [Abstract][Full Text] [Related]
4. Antigen identification for HLA class I- and HLA class II-restricted T cell receptors using cytokine-capturing antigen-presenting cells.
Lee MN; Meyerson M
Sci Immunol; 2021 Jan; 6(55):. PubMed ID: 33483338
[TBL] [Abstract][Full Text] [Related]
5. Determination of a Predictive Cleavage Motif for Eluted Major Histocompatibility Complex Class II Ligands.
Paul S; Karosiene E; Dhanda SK; Jurtz V; Edwards L; Nielsen M; Sette A; Peters B
Front Immunol; 2018; 9():1795. PubMed ID: 30127785
[TBL] [Abstract][Full Text] [Related]
6. Invariant chain as a vehicle to load antigenic peptides on human MHC class I for cytotoxic T-cell activation.
Wälchli S; Kumari S; Fallang LE; Sand KM; Yang W; Landsverk OJ; Bakke O; Olweus J; Gregers TF
Eur J Immunol; 2014 Mar; 44(3):774-84. PubMed ID: 24293164
[TBL] [Abstract][Full Text] [Related]
7. Distinguishing Signal From Noise in Immunopeptidome Studies of Limiting-Abundance Biological Samples: Peptides Presented by I-A
Nanaware PP; Jurewicz MM; Clement CC; Lu L; Santambrogio L; Stern LJ
Front Immunol; 2021; 12():658601. PubMed ID: 33995376
[TBL] [Abstract][Full Text] [Related]
8. Epitope distribution in ordered and disordered protein regions - part A. T-cell epitope frequency, affinity and hydropathy.
Mitić NS; Pavlović MD; Jandrlić DR
J Immunol Methods; 2014 Apr; 406():83-103. PubMed ID: 24614036
[TBL] [Abstract][Full Text] [Related]
9. A novel method to measure HLA-DM-susceptibility of peptides bound to MHC class II molecules based on peptide binding competition assay and differential IC(50) determination.
Yin L; Stern LJ
J Immunol Methods; 2014 Apr; 406():21-33. PubMed ID: 24583195
[TBL] [Abstract][Full Text] [Related]
10. A population response analysis approach to assign class II HLA-epitope restrictions.
Paul S; Dillon MBC; Arlehamn CSL; Huang H; Davis MM; McKinney DM; Scriba TJ; Sidney J; Peters B; Sette A
J Immunol; 2015 Jun; 194(12):6164-6176. PubMed ID: 25948811
[TBL] [Abstract][Full Text] [Related]
11. Endogenous HLA class II epitopes that are immunogenic in vivo show distinct behavior toward HLA-DM and its natural inhibitor HLA-DO.
Kremer AN; van der Meijden ED; Honders MW; Goeman JJ; Wiertz EJ; Falkenburg JH; Griffioen M
Blood; 2012 Oct; 120(16):3246-55. PubMed ID: 22889757
[TBL] [Abstract][Full Text] [Related]
12. Hunting down factor VIII in the immunopeptidome.
Hartholt RB; Peyron I; Voorberg J
Cell Immunol; 2016 Mar; 301():59-64. PubMed ID: 26610639
[TBL] [Abstract][Full Text] [Related]
13. Identification of promiscuous KIF20A long peptides bearing both CD4+ and CD8+ T-cell epitopes: KIF20A-specific CD4+ T-cell immunity in patients with malignant tumor.
Tomita Y; Yuno A; Tsukamoto H; Senju S; Kuroda Y; Hirayama M; Irie A; Kawahara K; Yatsuda J; Hamada A; Jono H; Yoshida K; Tsunoda T; Kohrogi H; Yoshitake Y; Nakamura Y; Shinohara M; Nishimura Y
Clin Cancer Res; 2013 Aug; 19(16):4508-20. PubMed ID: 23714729
[TBL] [Abstract][Full Text] [Related]
14. Analyzing the effect of peptide-HLA-binding ability on the immunogenicity of potential CD8+ and CD4+ T cell epitopes in a large dataset.
Wang S; Li J; Chen X; Wang L; Liu W; Wu Y
Immunol Res; 2016 Aug; 64(4):908-18. PubMed ID: 27094547
[TBL] [Abstract][Full Text] [Related]
15. Efficient presentation of known HLA class II-restricted MAGE-A3 epitopes by dendritic cells electroporated with messenger RNA encoding an invariant chain with genetic exchange of class II-associated invariant chain peptide.
Bonehill A; Heirman C; Tuyaerts S; Michiels A; Zhang Y; van der Bruggen P; Thielemans K
Cancer Res; 2003 Sep; 63(17):5587-94. PubMed ID: 14500399
[TBL] [Abstract][Full Text] [Related]
16. Construction and Screening of an Antigen-Derived Peptide Library Displayed on Yeast Cell Surface for CD4+ T Cell Epitope Identification.
Wen F; Smith MR; Zhao H
Methods Mol Biol; 2019; 2024():213-234. PubMed ID: 31364052
[TBL] [Abstract][Full Text] [Related]
17. Antigen-presenting cells and the selection of immunodominant epitopes.
Blum JS; Ma C; Kovats S
Crit Rev Immunol; 1997; 17(5-6):411-7. PubMed ID: 9419428
[TBL] [Abstract][Full Text] [Related]
18. Helper T cell epitope-mapping reveals MHC-peptide binding affinities that correlate with T helper cell responses to pneumococcal surface protein A.
Singh R; Singh S; Sharma PK; Singh UP; Briles DE; Hollingshead SK; Lillard JW
PLoS One; 2010 Feb; 5(2):e9432. PubMed ID: 20195541
[TBL] [Abstract][Full Text] [Related]
19. Defining HLA-II Ligand Processing and Binding Rules with Mass Spectrometry Enhances Cancer Epitope Prediction.
Abelin JG; Harjanto D; Malloy M; Suri P; Colson T; Goulding SP; Creech AL; Serrano LR; Nasir G; Nasrullah Y; McGann CD; Velez D; Ting YS; Poran A; Rothenberg DA; Chhangawala S; Rubinsteyn A; Hammerbacher J; Gaynor RB; Fritsch EF; Greshock J; Oslund RC; Barthelme D; Addona TA; Arieta CM; Rooney MS
Immunity; 2019 Oct; 51(4):766-779.e17. PubMed ID: 31495665
[TBL] [Abstract][Full Text] [Related]
20. Analysis of Major Histocompatibility Complex-Bound HIV Peptides Identified from Various Cell Types Reveals Common Nested Peptides and Novel T Cell Responses.
Rucevic M; Kourjian G; Boucau J; Blatnik R; Garcia Bertran W; Berberich MJ; Walker BD; Riemer AB; Le Gall S
J Virol; 2016 Oct; 90(19):8605-20. PubMed ID: 27440904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]